Pushkang Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 300

Employees

  • Latest Deal Type
  • Series D

  • Investors
  • 20

Pushkang General Information

Description

Developer of microfluid analysis biotechnology designed for the chronic disease management detection field. The company focuses on in vitro diagnostic (IVD) reagents and clinical laboratory analysis instruments, enabling biomedical researchers to better analyse fluid samples.

Contact Information

Formerly Known As
Shaoxing Pushikang Biological Technology Co.,Ltd., Shaoxing Pusikang Biotechnology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4th Floor, Building 2, Science and Technology Entrepreneurship Park
  • Number 398 Mahuan Road, Binhai New Area
  • Shaoxing, Zhejiang 312300
  • China
+86 400
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4th Floor, Building 2, Science and Technology Entrepreneurship Park
  • Number 398 Mahuan Road, Binhai New Area
  • Shaoxing, Zhejiang 312300
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pushkang Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series D) 29-Jul-2025 Completed Generating Revenue
10. Later Stage VC 26-Mar-2024 Completed Generating Revenue
9. Later Stage VC (Series C2) 28-Feb-2023 Completed Generating Revenue
8. Later Stage VC (Series C1) 24-Oct-2022 Completed Generating Revenue
7. Later Stage VC (Series C) 20-Feb-2021 Completed Generating Revenue
6. Later Stage VC (Series B1) 15-Dec-2020 Completed Generating Revenue
5. Later Stage VC (Series B) 01-Apr-2020 Completed Generating Revenue
4. Later Stage VC (Series A1) 06-Dec-2019 Completed Generating Revenue
3. Later Stage VC 21-May-2019 $807K Completed Generating Revenue
2. Early Stage VC (Series A) 03-Jan-2017 $807K Completed Generating Revenue
To view Pushkang’s complete valuation and funding history, request access »

Pushkang Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pushkang Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Shengshi Hongming Investment Fund Management Fund of Funds Minority
Chengdu Ledao Hechuang Investment Management Venture Capital Minority
Power Capital Limited Partner Minority
Beijing LF Capital PE/Buyout Minority
Kaiyuan Securities VC-Backed Company Minority
You’re viewing 5 of 20 investors. Get the full list »

Pushkang FAQs

  • When was Pushkang founded?

    Pushkang was founded in 2014.

  • Where is Pushkang headquartered?

    Pushkang is headquartered in Shaoxing, China.

  • What is the size of Pushkang?

    Pushkang has 300 total employees.

  • What industry is Pushkang in?

    Pushkang’s primary industry is Diagnostic Equipment.

  • Is Pushkang a private or public company?

    Pushkang is a Private company.

  • What is Pushkang’s current revenue?

    The current revenue for Pushkang is .

  • How much funding has Pushkang raised over time?

    Pushkang has raised $30.2M.

  • Who are Pushkang’s investors?

    Beijing Shengshi Hongming Investment Fund Management, Chengdu Ledao Hechuang Investment Management, Power Capital, Beijing LF Capital, and Kaiyuan Securities are 5 of 20 investors who have invested in Pushkang.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process